JLE

Hépato-Gastro & Oncologie Digestive

MENU

Upper gastro-intestinal bleeding: When and what to look for? Volume 25, supplement 4, Décembre 2018

Figures


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5

  • Figure 6

  • Figure 7

  • Figure 8

  • Figure 9

  • Figure 10

  • Figure 11

Tables

Authors
Hôpital Ambroise Paré, Service hépato-gastroentérologie, 9 avenue Charles De Gaulle, 92104 Boulogne Billancourt, France
* Tirés à part

Incidence of upper gastrointestinal bleeding (UGIB) is 122 cases for 100,000 inhabitants with a 10 to 15% mortality rate. UGIB is not externalized in 10% of cases and should be suspected even if there is an unexplained decrease in hemoglobin level. Diagnosis relies on gastrointestinal endoscopy (GIE), which has also a therapeutic aim. Initial management relies on the search for UGIB risk factors, for signs of hemorrhagic shock and on a blood test upon arrival. Glasgow-Blatchford score may help to decide between an outpatient management and a referral in intensive care unit and as well as to decide when to perform GIE. The most frequent causes are: ulcers/gastritis, variceal bleed, esophagitis, and Mallory-Weiss syndrome. Emergent pre therapeutic management includes volemic expansion with restrictive transfusion strategy, hemostasis correction and an appropriate pharmacological treatment.

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License